ArticleFrontiers in endocrinology2025
High fat diet-induced loss of pituitary plasticity in aging female mice with ablated leptin signaling in somatotropes.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Autocrine and paracrine regulation of pituitary endocrine cells.Frontiers in endocrinology · 2026Review
- Integrated pituitary adaptations to the low estrogen state.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: Somatotropes lacking leptin receptors (LEPR) produce less growth hormone and are poorly responsive to growth hormone releasing hormone (GHRH). Transcriptomic analysis reveals that the mutant somatotropes contain progenitor cell markers (Sox9+) and multiple pituitary hormone transcripts-( Objectives: This study examined how a high-fat diet (HFD) affected pituitary transcriptomic function in older (10-month) female mutants lacking leptin receptors (LEPR) in somatotropes and intact littermate controls. We hypothesized that pituitary cells from both the older control females and the female mutants would be greatly affected by the oxidative stress from the HFD. Methods: Mice were exposed to a 60% HFD for 16 weeks, followed by glucose tolerance testing and 3-day monitoring in metabolic cages (CLAMS). Pituitaries were harvested, cells dispersed and subjected to single cell-RNA-seq (scRNA-seq) with bioinformatic analysis. Serum was collected and analyzed for pituitary hormones and cytokines. Results: The HFD resulted in elevated serum leptin and IL-6 in both mutants and controls, and reduced serum growth hormone (GH) and prolactin (PRL) levels. However, adrenocorticotropin (ACTH) levels were elevated in controls but not mutants. Unexpectedly, whereas controls gained as much weight as younger females, somatotrope LEPR-null mutants on a HFD gained only 75% of the weight of controls, were more glucose tolerant, consumed less food, were more active in the metabolic cages, and had lower serum levels of insulin. Analysis of scRNA-seq revealed that the HFD induced differentially expressed genes (DEGs) in more distinct pituitary cell populations of older mice compared to previously reported findings in younger control females, indicating greater vulnerability in the older pituitary population. This was especially true in the mutant pituitary population. Ingenuity Pathway Analysis indicated that the DEGs included targets of critical upstream regulators important for pituitary cell function and plasticity (CREB, Fox01, cAMP, STAT3, insulin, TRH, GnRH, and leptin signaling pathways), with most pathways predicted to be downregulated by the HFD. Unlike controls, HFD-fed mutant cell populations exhibited DEGs consistent with the downregulation of translational regulatory pathways. Notably, the HFD reversed the increased expression of progenitor cell markers ( Conclusion: The findings supported our hypothesis that both aging and the mutation (loss of LEPR in somatotropes) would render these mice more sensitive to a HFD as more pituitary cell types were affected transcriptionally. Collectively, these findings indicate that HFD and/or obese state may compromise pituitary plasticity by down-regulating translational processes and reducing expression in cells that may have multipotential functions. The oxidative stress of a HFD may thus limit the expression of pituitary progenitor cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.